| Contact | Discussion | News | Publications | Site Map | |
![]() |
LIPID Metabolites And Pathways Strategy |
| About Lipid Classification Standards Experimental Data Databases Pathways Tools Protocols Home | |
|
Introduction
| Browse by lipid category
| Search by gene annotation
| Search by KEGG pathway
| Search by fold change ratio
| VAMPIRE Analysis
| GOby Analysis
Mouse-over the above links for more information |
IntroductionExperimental designCompactin is a potent competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, the rate-limiting enzyme in cholesterol biosynthesis. Experiments were conducted with RAW264.7 cells fed 10% fetal calf serum, as per protocol PP0000002800 (pdf). Measurements were taken at 0, 12, and 24hrs for: (i) compactin, (ii) Kdo2-Lipid A, (iii) compactin + Kdo2-Lipid A. and (iv) control. Array Design45,214 spots on the array41,034 data spots 38,838 unique probes (6428 probes have no gene id) 21,609 unique mouse genes Each gene was represented by 1 - 9 probes Each probe was spotted 1 or 10 times Data NormalizationData normalization was performed as described in J Mol Endocrinol Sasik et al. 33 (1): 1 (PDF) |